Evidence map›Paper›PMID 41646313›Full record

ArticleResearch square2026

Perspectives on Harm Reduction Kit Implementation in Heterogeneous Outpatient Clinics.

Raagini Jawa, Margaret Shang, Austen Markus, Megan Hamm, José G Luiggi-Hernández, Flor de Abril Cameron, Gary McMurtrie, Olivia Studnicki, Mary Hawk, Devon K Check and 2 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Raagini JawaUniversity of Pittsburgh School of Medicine.
Margaret ShangUniversity of Pittsburgh School of Medicine.
Austen MarkusUniversity of Pittsburgh School of Medicine.
Megan HammUniversity of Pittsburgh School of Medicine.
José G Luiggi-HernándezUniversity of Pittsburgh School of Medicine.
Flor de Abril CameronUniversity of Pittsburgh School of Medicine.
Gary McMurtrieUniversity of Pittsburgh School of Medicine.
Olivia StudnickiUniversity of Pittsburgh School of Medicine.
Mary HawkUniversity of Pittsburgh School of Public Health.
Devon K CheckDuke University School of Medicine.
Jessica MerlinUniversity of Pittsburgh School of Medicine.
Jane M LiebschutzUniversity of Pittsburgh School of Medicine.

Funding

Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP)RM1DA055311 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HAMM, MEGAN, MERLIN, JESSICA S · 2021 to 2025
$12.7M
University of Pittsburgh Collaboration in Addiction Training Scholars (PittCATS) ProgramK12DA050607 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jane M. Liebschutz, Erin L Winstanley · 2020 to 2026
$3.2M
NIDA NIH HHS K12 DA050607NIDA NIH HHS RM1 DA055311
6 · The paper itself

Abstract

Background: The evolving U.S. drug market has fueled a public health crisis with rising drug use-associated morbidity and mortality, revealing a mismatch between current abstinence-based addiction care and the needs of people who use drugs (PWUD) to access evidence-based harm reduction services (HRS). Co-locating HRS into outpatient clinics could reduce mortality and improve clinical outcomes. We investigated barriers and facilitators of HRS implementation through kit distribution at three heterogenous outpatient addiction clinics using pre- and post-implementation focus groups. Methods: We conducted qualitative description approach via 1-hour virtual focus groups and individual interviews with clinic staff and providers both pre- and post-implementation of kit distribution. Interview guides were based on the Consolidated Framework for Implementation Research to assess anticipated and actual implementation barriers and facilitators. Interviews were analyzed using thematic analysis. Results: Five providers and six staff participated in pre-implementation data collection. Dominant themes pre-implementation included participant enthusiasm for HRS integration and anticipated barriers of personal knowledge and external stigma against PWUD. Six providers and five staff participated post-implementation. Participants reported few actual barriers, of which external stigma and lack of funding for program sustainability were most prominent. Conclusions: Implementation of HRS in outpatient addiction clinics was well-received by providers and staff and supported by pre-implementation trainings, site champions, and favorable implementation environments. Further efforts are needed to reduce stigma in the greater community and achieve sustainable funding for HRS.

Indexed as

harm reductionimplementation scienceoutpatient clinics

Identifiers

PMID41646313
PMCPMC12869684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.